FDA MedWatch - MegMan Performance Booster Capsules by Junp:

If your email program has trouble displaying this email, view as a webpage.

TOPIC: MegMan Performance Booster Capsules by Junp: Recall - Due to the Presence of Tadalafil

AUDIENCE: Consumer, Health Professional, Pharmacy

ISSUE: Junp is recalling Lot number 2010291 of MegMan Performance Booster capsules due to undeclared tadalafil. Tadalafil is an ingredient in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. The presence of tadalafil in MegMan Performance Booster makes this product an unapproved drug for which the safety and efficacy has not been established.

Consumers with underlying medical issues who take MegMan Performance Booster Capsules with undeclared tadalafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates.

To date, Junp LLC has not received any reports of adverse events related to this recall.

For more information about this recall, click on the red button "Read Recall" below.

BACKGROUND: The product is marketed as a dietary supplement for male sexual enhancement. 

RECOMMENDATIONS: On December 17, 2022, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encourages online marketplaces to ensure these products are not sold on their platforms. 

• Consumers that have MegMan Performance Booster which is being recalled should stop using the product.
• Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
• Junp LLC is notifying its customers and is arranging return of all recalled products. 

Consumers and health professionals are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.